1. Home
  2. SKYE vs SPWH Comparison

SKYE vs SPWH Comparison

Compare SKYE & SPWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKYE
  • SPWH
  • Stock Information
  • Founded
  • SKYE 2012
  • SPWH 1986
  • Country
  • SKYE United States
  • SPWH United States
  • Employees
  • SKYE N/A
  • SPWH N/A
  • Industry
  • SKYE Biotechnology: Pharmaceutical Preparations
  • SPWH Other Specialty Stores
  • Sector
  • SKYE Health Care
  • SPWH Consumer Discretionary
  • Exchange
  • SKYE Nasdaq
  • SPWH Nasdaq
  • Market Cap
  • SKYE 80.7M
  • SPWH 68.9M
  • IPO Year
  • SKYE N/A
  • SPWH 2014
  • Fundamental
  • Price
  • SKYE $1.98
  • SPWH $1.89
  • Analyst Decision
  • SKYE Buy
  • SPWH Strong Buy
  • Analyst Count
  • SKYE 6
  • SPWH 5
  • Target Price
  • SKYE $16.60
  • SPWH $2.80
  • AVG Volume (30 Days)
  • SKYE 223.6K
  • SPWH 300.7K
  • Earning Date
  • SKYE 05-08-2025
  • SPWH 06-03-2025
  • Dividend Yield
  • SKYE N/A
  • SPWH N/A
  • EPS Growth
  • SKYE N/A
  • SPWH N/A
  • EPS
  • SKYE N/A
  • SPWH N/A
  • Revenue
  • SKYE N/A
  • SPWH $1,197,633,000.00
  • Revenue This Year
  • SKYE N/A
  • SPWH $2.37
  • Revenue Next Year
  • SKYE N/A
  • SPWH $2.12
  • P/E Ratio
  • SKYE N/A
  • SPWH N/A
  • Revenue Growth
  • SKYE N/A
  • SPWH N/A
  • 52 Week Low
  • SKYE $1.14
  • SPWH $0.92
  • 52 Week High
  • SKYE $12.11
  • SPWH $4.44
  • Technical
  • Relative Strength Index (RSI)
  • SKYE 50.21
  • SPWH 52.51
  • Support Level
  • SKYE $1.88
  • SPWH $1.85
  • Resistance Level
  • SKYE $2.28
  • SPWH $2.12
  • Average True Range (ATR)
  • SKYE 0.23
  • SPWH 0.12
  • MACD
  • SKYE 0.00
  • SPWH -0.03
  • Stochastic Oscillator
  • SKYE 40.00
  • SPWH 13.33

About SKYE Skye Bioscience Inc. Common Stock

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

About SPWH Sportsman's Warehouse Holdings Inc.

Sportsman's Warehouse Holdings Inc together with its subsidiaries operates as an outdoor sporting goods retailer. It provides a one-stop shopping experience that equips customers with the right quality, brand name hunting, shooting, fishing, and camping gear to maximize enjoyment of the outdoors. The company offers products in the categories of Camping, Apparel, Fishing, Footwear, Hunting and shooting, and Optics, Electronics, Accessories, and Other products. It provides products such as Backpacks, Jackets, Camp essentials, Hiking boots, GPS devices, ATV accessories and Fishing rods, among others.

Share on Social Networks: